SCHEMBL19080087

SCHEMBL19080087

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(ccc7c8ccc9ccccc9c8oc67)c5)c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 13/20 0.50
CYP1B1 Q16678 13/20 0.50
GPR84 Q9NQS5 1/20 0.42
ARSA P15289 1/20 0.41
CDC25A P30304 1/20 0.41
CDC25C P30307 1/20 0.41
CYP1A2 P05177 12/20 0.40
ABCB1 P08183 2/20 0.40
ABCC1 P33527 2/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
PRKDC P78527 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PDE5A O76074 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080023 0.92 CYP1A1 (0.46) CYP1A1CYP1B1GPR84ARSACDC25A
SCHEMBL19080092 0.91 CYP1A1 (0.42) CYP1A1CYP1B1GPR84ARSACDC25A
SCHEMBL20127536 0.91 CYP1A1 (0.47) CYP1A1CYP1B1GPR84ARSACDC25A
SCHEMBL19080058 0.90 CYP1A1 (0.45) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080101 0.90 CYP1A1 (0.56) CYP1A1CYP1B1GPR84CYP1A2ABCB1
SCHEMBL16067553 0.90 CYP1A1 (0.46) CYP1A1CYP1B1GPR84ARSACDC25A
SCHEMBL22062631 0.90 CYP1A1 (0.46) CYP1A1CYP1B1GPR84ARSACDC25A
SCHEMBL19080086 0.90 CYP1A1 (0.43) CYP1A1CYP1B1GPR84ARSACDC25A
SCHEMBL17931958 0.89 CYP1A1 (0.48) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080090 0.89 CYP1A1 (0.43) CYP1A1CYP1B1GPR84ARSACDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885GPR84 2425/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885GPR84 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.